Homozygous SMN2 deletion is a major risk factor among twenty-five Korean sporadic amyotrophic lateral sclerosis patients

Yonsei Medical Journal

Volumn 53, Issue 1, 2012, Pages 53-57

  Lee, Jun Beom ^a   Lee, Kyung A ^a   Hong, Ji Man ^b   Suh, Gyoung Im ^c   Choi, Young Chul ^a  

^a Yonsei University College of Medicine   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

^c Uijeongbu St Mary's Hospital   (South Korea)

Author keywords

Age of onset; Amyotrophic lateral sclerosis; Disease susceptibility; Severity of illness index; SMN1; SMN2

Indexed keywords

SURVIVAL MOTOR NEURON PROTEIN 1; SURVIVAL MOTOR NEURON PROTEIN 2;

ADULT; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; COPY NUMBER VARIATION; DISEASE DURATION; DISEASE SEVERITY; FEMALE; GENE DELETION; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HOMOZYGOSITY; HUMAN; MALE; MEDICAL RESEARCH COUNCIL SCALE; ONSET AGE; RATING SCALE;

ADOLESCENT; ADULT; AGE OF ONSET; AMYOTROPHIC LATERAL SCLEROSIS; ASIAN CONTINENTAL ANCESTRY GROUP; GENE DELETION; HOMOZYGOTE; HUMANS; MIDDLE AGED; REPUBLIC OF KOREA; RISK FACTORS; SURVIVAL OF MOTOR NEURON 2 PROTEIN; YOUNG ADULT;

EID: 84255184836     PISSN: 05135796     EISSN: None     Source Type: Journal    
DOI: 10.3349/ymj.2012.53.1.53     Document Type: Article

References (11)

1. Veldink JH, van den Berg LH, Cobben JM, Stulp RP, De Jong JM, Vogels OJ, et al. Homozygous deletion of the survival motor neuron 2 gene is a prognostic factor in sporadic ALS. Neurology 2001;56:749-52.
2. Majoor-Krakauer D, Ottman R, Johnson WG, Rowland LP. Familial aggregation of amyotrophic lateral sclerosis, dementia, and Parkinson's disease: evidence of shared genetic susceptibility. Neurology 1994;44:1872-7.
3. Schymick JC, Talbot K, Traynor BJ. Genetics of sporadic amyotrophic lateral sclerosis. Hum Mol Genet 2007;16:R233-42.
4. Veldink JH, Kalmijn S, Van der Hout AH, Lemmink HH, Groeneveld GJ, Lummen C, et al. SMN genotypes producing less SMN protein increase susceptibility to and severity of sporadic ALS. Neurology 2005;65:820-5.
5. Burghes AH, Beattie CE. Spinal muscular atrophy: why do low levels of survival motor neuron protein make motor neurons sick? Nat Rev Neurosci 2009;10:597-609.
6. Echaniz-Laguna A, Guiraud-Chaumeil C, Tranchant C, Reeber A, Melki J, Warter JM. Homozygous exon 7 deletion of the SMN centromeric gene (SMN2): a potential susceptibility factor for adult-onset lower motor neuron disease. J Neurol 2002;249:290-3.
7. Brooks BR. El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial "Clinical limits of amyotrophic lateral sclerosis" workshop contributors. J Neurol Sci 1994;124 Suppl: 96-107.
8. Kim J, Lee SG, Choi YC, Kang SW, Lee JB, Choi JR, et al. Association between survivor motor neuron 2 (SMN2) gene homozygous deletion and sporadic lower motor neuron disease in a Korea an population. Ann Clin Lab Sci 2010;40:368-74.
9. Moulard B, Salachas F, Chassande B, Briolotti V, Meininger V, Malafosse A, et al. Association between centromeric deletions of the SMN gene and sporadic adult-onset lower motor neuron disease. Ann Neurol 1998;43:640-4.
10. Corcia P, Camu W, Halimi JM, Vourc'h P, Antar C, Vedrine S, et al. SMN1 gene, but not SMN2, is a risk factor for sporadic ALS. Neurology 2006;67:1147-50.
11. Zou T, Ilangovan R, Yu F, Xu Z, Zhou J. SMN protects cells against mutant SOD1 toxicity by increasing chaperone activity. Biochem Biophys Res Commun 2007;364:850-5.